Despite the disappointing data, the government is still proceeding with the fourth dosage for the elderly and those who are immunocompromised. One would think a country with some of the world's greatest scientific minds would heed the advice of those minds, but the government seems set on ignoring the results and maintaining the 'Jabfest'.
The study of over 270 medical staff in Israel discovered that the fourth shot just raised antibodies "a little" from those who were triple-vaccinated. Participants provided with four doses were just "a bit less" likely to test positive for the mutant strain than those who had three shots.
WATCH: THE AG'S RAN ON "GETTING" TRUMP
The findings were true for both Pfizer and Moderna, and will reignite the debate regarding whether constant boosting is required.
WATCH: THE TIMING OF TRUMP'S TRIAL, WHY NOW?
Researchers from the Sheba Medical Center in Tel Aviv, who ran the trial, announced those who grew infected had very mild symptoms or none at all.
In a press conference, author Dr. Gili Regev-Yochay explained: "These are very preliminary results. This is before any publication. But we're giving it out since we understand the urgency of the public to get any information possible about the fourth dose."
SECURITY IN OVERDRIVE: HOME DEPOT'S UNCONVENTIONAL RESPONSE TO NEW YORK'S CRIME CRISIS
The results came as a U.K. Government adviser became the latest senior figure to warn against repeated mass vaccinations, recommending a targeted approach like what is done for the flu.
Last week, European Union regulators explained that boosting too frequently could actually drain the immune system.
THREAT OR PROMISE? DEMOCRATIC HOPEFUL'S CONTROVERSIAL MESSAGE: "DIE MAGA DIE"
The World Health Organization has called on vaccine makers to make variant-proof jabs to avoid countries having to revaccinate every few months.
WHITE HOUSE WEIGHING GAME-CHANGING SHIFT IN IMMIGRATION POLICY
Israel was the first nation in the world to roll out boosters last year and became one of the only countries to begin dishing out fourth jabs last month to fight Omicron.
Studies have since shown that three jabs are holding up well against serious illness, offering roughly 88 percent protection from hospitalization, even if Omicron can slip past the immune system and cause infection more quickly.
TUCKER CARLSON TELLS JOE ROGAN WHAT POLITICIANS ARE SO AFRAID OF TODAY...
Dr. Regev-Yochay explained that the choice to give the fourth vaccine to over-60s and immunocompromised patients was the right one.
Over half a million people in those two risk groups have been quadruple-jabbed so far.
Though, she admitted the small extra benefit was not enough to justify a wider rollout to the whole adult population.
"SQUAD" REP. PRAMILA JAYAPAL'S SLIP-UP EXPOSES REAL AGENDA BEHIND TRUMP IMPEACHMENTS
"Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus," she explained in a press conference.
"We see an increase in antibodies, higher than after the third dose. However, we see many infected with Omicron who received the fourth dose."
"Granted, a bit less than in the control group, but still a lot of infections."
"The bottom line is that the vaccine is excellent against the Alpha and Delta [variants], for Omicron it's not good enough."
The team studied the defense of the Pfizer booster in 154 people after two weeks and the Moderna booster in 120 people after one week.
They were compared to people who had been triple-jabbed with Pfizer, which is the shot Israel has solely relied on thus far.
Discover alternative ideas that will make you think
Engage in mind bending debate
Earn points, rise in rank, have fun
